V

VYNE Therapeutics
D

VYNE

0.92870
USD
0.03
(3.44%)
مغلق
حجم التداول
8,027
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
31,004,701
أصول ذات صلة المقالات
المزيد

العنوان: VYNE Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.